Search Results 431-440 of 17559 for Toxin

1. Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis - Mayo Clinic

   Clostridium difficile toxin, ova, or parasites present. Systemic or rectal corticosteroid use within 4 weeks prior to the Screening Visit. Topical ...

2. AMG 181 in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

   difficile toxin at screening; Any uncontrolled or clinically significant systemic disease; Known to have tested positive for hepatitis B virus surface antigen ...

3. Clinical trials - Oncology (Medical)

   In traditional Chinese medicine, it is used for enhancing function and removing toxins, as well as for cancer, hepatitis, and infections. There is previous ...

4. A Study to Evaluate Feasibility of In Vivo Sensitivity Screen Using Direct Tumor Microinjection and FDG-PET in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer - Mayo Clinic

   Radio- or toxin immunoconjugates ≤ 4 weeks prior to registration;; Radiation therapy to the injected area ≤ 2 weeks prior to registration;; Major surgery ...

5. Clinical trials - Oncology (Medical)

   In traditional Chinese medicine, it is used for enhancing function and removing toxins, as well as for cancer, hepatitis, and infections. There is previous ...

6. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis - Mayo Clinic

   Subjects should not have a planned botulism toxin or sympathectomy during their participation in the study. Subjects with gangrene or digital amputation ...

7. A Study to Evaluate the Safety and Effectiveness of RM-131 Administered to Patients with Vomiting Symptoms and Moderate to Severe Diabetes Caused Paralysis of the Stomach - Mayo Clinic

   History of pyloric injection of botulinum toxin within 6 months of screening; Clinical suspicion of upper gastrointestinal (GI) obstruction (e.g., peptic ...

8. A Study to Evaluate the Characteristics and Role of Mucosal Microbiome after Treatment of Clostridium-difficile Infection - Mayo Clinic

   difficile toxin PCR testing and clinical evidence of diarrhea who are currently undergoing treatment or have completed treatment within the last 6 months.

9. Tetanus immune globulin (intramuscular route) - Side effects & dosage - Mayo Clinic

   Tetanus immune globulin works by giving your body the antibodies it needs to protect it against tetanus infection. This is called passive protection. This ...

10. Recording Pelvic Health Signals After Stimulation of a Sacral Nerve - Mayo Clinic

    Treatment of voiding behavior with botulinum toxin in the past 9 months or any plan to have botulinum toxin treatment during the study. Treatment of ...